TY - JOUR
T1 - Gastrointestinal effects of diets low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols
AU - Quigley, Eamonn M.M.
N1 - Funding Information:
Supported in part by the Underwood Center for Digestive Disorders and the Josephine Hughes Sterling Foundation.
Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2022/7/1
Y1 - 2022/7/1
N2 - Purpose of reviewFood ingestion is an exacerbator of gastrointestinal symptoms, regardless of origin. Sufferers mistakenly assume that they have suffered an allergic reaction to a given food. Although classical IgE-mediated allergic reactions are rarely culpable, evidence for a role for intolerance to certain carbohydrates in irritable bowel syndrome (IBS) and related conditions increases. This review assesses the status of a commonly implicated group of poorly absorbed carbohydrates (fermentable oligosaccharides, disaccharides, monosaccharides and polyols - FODMAPs) in gastrointestinal pathophysiology.Recent findingsAlthough evidence of efficacy for low FODMAP diets in IBS accumulates, the magnitude of this effect has declined in recent studies. Comparisons to other dietary approaches have revealed conflicting results; some suggest superiority, others find parity. Concerns had been raised regarding long-term nutritional, psychological and microbiological impacts of FODMAP restriction; providing that the diet is administered in the recommended manner, these do not appear to be clinically important. The mechanisms whereby FODMAPs cause gastrointestinal symptoms continue to be explored.SummaryFODMAPS induce gastrointestinal symptoms in susceptible individuals and their restriction provides clinical benefits. The magnitude of these benefits, the superiority of FODMAP restriction over other dietary approaches and the mechanisms of its effects continue to be defined.
AB - Purpose of reviewFood ingestion is an exacerbator of gastrointestinal symptoms, regardless of origin. Sufferers mistakenly assume that they have suffered an allergic reaction to a given food. Although classical IgE-mediated allergic reactions are rarely culpable, evidence for a role for intolerance to certain carbohydrates in irritable bowel syndrome (IBS) and related conditions increases. This review assesses the status of a commonly implicated group of poorly absorbed carbohydrates (fermentable oligosaccharides, disaccharides, monosaccharides and polyols - FODMAPs) in gastrointestinal pathophysiology.Recent findingsAlthough evidence of efficacy for low FODMAP diets in IBS accumulates, the magnitude of this effect has declined in recent studies. Comparisons to other dietary approaches have revealed conflicting results; some suggest superiority, others find parity. Concerns had been raised regarding long-term nutritional, psychological and microbiological impacts of FODMAP restriction; providing that the diet is administered in the recommended manner, these do not appear to be clinically important. The mechanisms whereby FODMAPs cause gastrointestinal symptoms continue to be explored.SummaryFODMAPS induce gastrointestinal symptoms in susceptible individuals and their restriction provides clinical benefits. The magnitude of these benefits, the superiority of FODMAP restriction over other dietary approaches and the mechanisms of its effects continue to be defined.
KW - celiac disease
KW - diets
KW - disaccharides
KW - fermentable oligosaccharides
KW - inflammatory bowel disease
KW - irritable bowel syndrome
KW - microbiome
KW - monosaccharides and polyols
KW - Carbohydrates
KW - Monosaccharides/adverse effects
KW - Humans
KW - Oligosaccharides/adverse effects
KW - Diet, Carbohydrate-Restricted/adverse effects
KW - Gastrointestinal Diseases/etiology
KW - Fermentation
KW - Diet
KW - Irritable Bowel Syndrome
KW - Disaccharides/adverse effects
KW - Polymers
UR - http://www.scopus.com/inward/record.url?scp=85132961286&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132961286&partnerID=8YFLogxK
U2 - 10.1097/MCO.0000000000000841
DO - 10.1097/MCO.0000000000000841
M3 - Review article
C2 - 35762162
AN - SCOPUS:85132961286
SN - 1363-1950
VL - 25
SP - 260
EP - 264
JO - Current Opinion in Clinical Nutrition and Metabolic Care
JF - Current Opinion in Clinical Nutrition and Metabolic Care
IS - 4
ER -